₹1,500-crore Biopharma Mission may focus on dengue, HPV vaccines

Aims to accelerate early leads through product-development pipeline

Read More
Publication Date: 
29/05/2017
Business Line (New Delhi)
Tags:
Vaccination, Dengue, Vector Borne Diseases, World Bank, Medical Research, Health